Risk of geographic atrophy in the comparison of age-related macular degeneration treatments trials.

@article{Grunwald2014RiskOG,
  title={Risk of geographic atrophy in the comparison of age-related macular degeneration treatments trials.},
  author={Juan E. Grunwald and Ebenezer Daniel and Jiayan Huang and Gui-shuang Ying and Maureen G. Maguire and Cynthia A. Toth and Glenn J. Jaffe and Stuart L. Fine and Barbara A. Blodi and Michael L. Klein and Alison A Martin and Stephanie A. Hagstrom and Daniel F. Martin},
  journal={Ophthalmology},
  year={2014},
  volume={121 1},
  pages={
          150-161
        }
}
PURPOSE To describe risk factors for geographic atrophy (GA) in the Comparison of Age-related Macular Degeneration Treatments Trials (CATT). DESIGN Cohort within a randomized clinical trial. PARTICIPANTS We analyzed 1024 CATT patients with no GA visible on color fundus photographs (CFPs) and/or fluorescein angiograms (FAs) at enrollment. METHODS Eyes were assigned to ranibizumab (0.5 mg) or bevacizumab (1.25 mg) treatment and to a 2-year monthly or pro re nata (PRN) injection regimen, or… CONTINUE READING
113 Extracted Citations
28 Extracted References
Similar Papers

Citing Papers

Publications influenced by this paper.
Showing 1-10 of 113 extracted citations

Referenced Papers

Publications referenced by this paper.
Showing 1-10 of 28 references

CATT Research Group. Risk of geographic atrophy in the comparison of agerelated macular degeneration treatments trials

  • JE Grunwald, E Daniel, J Huang
  • Ophthalmology
  • 2014

Growth of geographic atrophy on fundus auto fl uorescence and polymorphisms of CFH , CFB , C 3 , FHR 1 - 3 , and ARMS 2 in age - related macular degeneration

  • J Caire, S Recalde, A Velazquez-Villoria
  • JAMA Ophthalmol
  • 2014

Risk of geographic atrophy in the comparison of age - related macular degeneration treatments trials

  • FC DeCroos, CA Toth, SS Stinnett
  • Ophthalmology
  • 2014

Similar Papers

Loading similar papers…